Pfizer begins next phase of trial to study safety of its COVID-19 antiviral pill in children

Pfizer announced this morning that it has initiated the next phase of a clinical trial to evaluate the safety and efficacy of its COVID-19 antiviral pill, Paxlovid, in children ages 6 to 17.

More Stories

00:22

Cold Spring Village Hall closed due to COVID-19 surge and staff shortages

Hometown Heroes in the Hudson Valley

Hometown Heroes in New York City

00:33

US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case

Hometown Heroes in Connecticut

01:28

Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines